Fractionated stereotactic Radiotherapy for Brainstem Metastases - Clinical Outcomes and Prognostic Factors

被引：0
|
作者：
Kraemer, Anna [1 ]
Hahnemann, Laura [1 ]
Schunn, Fabian [1 ]
Fink, Christoph [1 ]
Hoerner-Rieber, Juliane [1 ]
Eichkorn, Tanja [2 ]
Deng, Maximilian [2 ]
Lang, Kristin [1 ]
Meixner, Eva [1 ]
Weykamp, Fabian [1 ]
Debus, Juergen Peter [1 ]
Koenig, Laila [1 ]
机构：
[1] Univ Klinikum Heidelberg, Radioonkol & Strahlentherapie, Heidelberg, Germany
[2] Radioonkol & Strahlentherapie, Heidelberg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
VS01-4-jD
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [1] Fractionated stereotactic radiotherapy of brainstem metastases - Clinical outcome and prognostic factors
    Kraemer, Anna
    Hahnemann, Laura
    Schunn, Fabian
    Grott, Christoph A.
    Thomas, Michael
    Christopoulos, Petros
    Lischalk, Jonathan W.
    Hoerner-Rieber, Juliane
    Hoegen-Sassmannshausen, Philipp
    Eichkorn, Tanja
    Deng, Maximilian Y.
    Meixner, Eva
    Lang, Kristin
    Paul, Angela
    Weykamp, Fabian
    Debus, Juergen
    Koenig, Laila
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2025, 50
  • [2] Outcomes and Prognostic Factors for Patients With Brainstem Metastases Undergoing Stereotactic Radiosurgery
    Hatiboglu, Mustafa Aziz
    Chang, Eric L.
    Suki, Dima
    Sawaya, Raymond
    Wildrick, David M.
    Weinberg, Jeffrey S.
    NEUROSURGERY, 2011, 69 (04) : 796 - 806
  • [3] Outcomes and Prognostic Factors for Patients With Brainstem Metastases Undergoing Stereotactic Radiosurgery COMMENT
    Sheehan, Jason
    NEUROSURGERY, 2011, 69 (04) : 806 - 806
  • [4] Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases - Clinical outcome and prognostic factors
    Hahnemann, L.
    Kraemer, A.
    Fink, C.
    Jungk, C.
    Thomas, M.
    Christopoulos, P.
    Lischalk, J. W.
    Meis, J.
    Hoerner-Rieber, J.
    Eichkorn, T.
    Deng, M.
    Lang, K.
    Paul, A.
    Meixner, E.
    Weykamp, F.
    Debus, J.
    Koenig, L.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46
  • [5] Fractionated stereotactic radiotherapy of the tumor bed after brain metastasis resection - clinical outcomes and prognostic factors
    Hahnemann, Laura
    Kraemer, Anna
    Fink, Christoph
    Hoerner-Rieber, Juliane
    Eichkorn, Tanja
    Deng, Maximilian
    Lang, Kristin
    Meixner, Eva
    Weykamp, Fabian
    Debus, Juergen Peter
    Koenig, Laila
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S116 - S116
  • [6] Clinical outcomes and a new Prognostic Index in Stereotactic Radiotherapy for Brain Metastases
    Lucarelli, Marco
    Bonelli, Rosario
    Trignani, Marianna
    Di Nicola, Marta
    Porreca, Annamaria
    Genovesi, Domenico
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S865 - S867
  • [7] Fractionated stereotactic radiotherapy of astrocytomas WHOII: Prognostic factors
    Plathow, C
    Schulz-Ertner, D
    Thilmann, C
    Zuna, I
    Schlemmer, HP
    Wannenmacher, M
    Debus, JJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 48 - 48
  • [8] Clinical Outcomes and Prognostic Factors of Fractionated Stereotactic Radiosurgery for Brain Metastases ≥20 mm as a Potential Alternative to Surgery
    Ogawa, Hiroaki
    Ito, Kei
    Karasawa, Katsuyuki
    WORLD NEUROSURGERY, 2022, 162 : E141 - E146
  • [9] Prognostic factors in stereotactic body radiotherapy of lung metastases
    Borm, K. J.
    Oechsner, M.
    Schiller, K.
    Peeken, J. C.
    Dapper, H.
    Munch, S.
    Kroll, L.
    Combs, S. E.
    Duma, M. N.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (10) : 886 - 893
  • [10] Stereotactic body radiotherapy of bone metastases in oligometastatic disease: prognostic factors of oncologic outcomes
    Ursino, Stefano
    Montrone, Sabrina
    Cantarella, Martina
    Menghini, Valentina
    Matteucci, Fabrizio
    Mazzotti, Valentina
    Fiorica, Francesco
    Fedele, David
    Erba, Paola
    Morganti, Riccardo
    Fabrini, Maria Grazia
    Caramella, Davide
    TUMORI JOURNAL, 2016, 102 (01): : 59 - 64
12345